Sanofi must pay up to $109M for Hyalgan kickbacks

Share this article:
Drugmakers Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LCC will pay up to $109 million in a settlement over an alleged scheme to provide doctors with free units of its knee-injection drug Hyalgan in return for purchase of the treatment.

The action, which was announced Dec. 19, also settled claims that the Paris-based company reported an average sales price (ASP) that omitted the free units of the arthritis-related pain reliever between 2005 and 2009. That led to government overpayment on drug reimbursement rates for Hyalgan and the competing Supartz.

The penalty is the result of information from former Sanofi sales representative Mark Giddarie. The Department of Justice said Giddarie will receive $18.5 million as his share of the settlement proceeds. Multiple states will also share in the federal government's recovery.

Bridgewater, N.J.-based Sanofi US issued a statement saying it “is pleased to have reached a resolution” in the matter.

Share this article:

More in News

Antipsychotics reduction goal is 25% by end of 2015, CMS and provider groups announce

Antipsychotics reduction goal is 25% by end of ...

Long-term care providers are being asked to reduce the use of antipsychotic medications among residents by 25% by the end of 2015, and 30% by the end of 2016. Providers ...

CDC issues new guidelines on pneumococcal vaccine, says LTC flu vaccination rates remain low

CDC issues new guidelines on pneumococcal vaccine, says ...

Long-term care workers continued to have low rates of flu vaccination last season, despite there being 92% vaccination coverage overall among physicians and nurses, the Centers for Disease Control and ...

AL operators accused of withholding $2M in unpaid overtime, minimum wages ...

Four California assisted living operators are facing eight felony charges related to wage theft, tax and insurance violations, according to local reports.